Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here?

Author： Urban Thomas J   Goldstein David B   Watkins Paul B  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.7, 2012-05, pp. : 735-738

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Acetaminophen safety and hepatotoxicity – where do we go from here?

By Amar Patrick J   Schiff Eugene R  

Expert Opinion on Drug Safety, Vol. 6, Iss. 4, 2007-07 ,pp. : 341-355

Informa Healthcare

Access to resources Recommend Favorite

Where Do We Go from Here? The Importance of Initial Values

By Mehta M.A.  

Neuropsychopharmacology, Vol. 27, Iss. 5, 2002-11 ,pp. : 879-880

Elsevier

Access to resources Recommend Favorite

Contingency Management for Smoking Cessation: Where Do We Go from Here?

By  

Current Drug Abuse Reviews, Vol. 1, Iss. 3, 2008-11 ,pp. : 340-349

Bentham Science Publishers

Access to resources Recommend Favorite

Developing a vaccine against congenital CMV infection: what have we learned from animal models? Where should we go next?

By Schleiss Mark R  

Future Virology, Vol. 8, Iss. 12, 2013-12 ,pp. : 1161-1182

Future Medicine

Access to resources Recommend Favorite

COX-2 controversy: where are we and where do we go from here?

By Khanna Dinesh  

Inflammopharmacology, Vol. 13, Iss. 4, 2005-09 ,pp. : 395-402

VSP

Access to resources Recommend Favorite